Who Exports Quinine from India — 236 Suppliers Behind a $19.3M Market
India's quinine export market is supplied by 236 active exporters who collectively shipped $19.3M across 1,510 shipments. STRIDES PHARMA SCIENCE LIMITED leads with a 24.4% market share, followed by SIDHAANT LIFE SCIENCES PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED. The top 5 suppliers together control 42.1% of total export value, reflecting a moderately competitive market structure.
Top Quinine Exporters from India — Ranked by Export Value
STRIDES PHARMA SCIENCE LIMITED is the leading quinine exporter from India, holding a 24.4% share of the $19.3M market across 1,510 shipments from 236 exporters. The top 5 suppliers — STRIDES PHARMA SCIENCE LIMITED, SIDHAANT LIFE SCIENCES PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED, SYNCOM FORMULATIONS (INDIA) LIMITED — collectively control 42.1% of total export value, indicating a competitive market. Individual shares are: STRIDES PHARMA SCIENCE LIMITED (24.4%), SIDHAANT LIFE SCIENCES PRIVATE LIMITED (5.4%), INTAS PHARMACEUTICALS LIMITED (5.3%), CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED (3.5%), SYNCOM FORMULATIONS (INDIA) LIMITED (3.3%).
Top Quinine Exporters from India
Ranked by export value · 236 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | STRIDES PHARMA SCIENCE LIMITED QUININE SULFATE TABLETS [200MG] [FC]QUININE SULFATE TABLETSQUININE SULFATE TABLETS [200MG] [FC]206 | $4.7M | 2 | 24.4% |
| 2 | SIDHAANT LIFE SCIENCES PRIVATE LIMITED QUININE SULFATE TABLETS BP 300 MG NOSQUININE 300MG CP BLISTER (OTHER DETAILSQUININE SULPHATE | $1.0M | 3 | 5.4% |
| 3 | INTAS PHARMACEUTICALS LIMITED QUININE SULFATE TABLETS BP 300 MGPHARMACEUTICAL PRODUCTS QUININE SULPHA | $1.0M | 4 | 5.3% |
| 4 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED STERILE QUININE DIHYDROCHLORIDE CONCENTRQUININE DIHYDROCHLORIDE INJ. 600 MG/ 2 MHL MEDICINES QUININE SULPHATE 300MG TABL | $682.7K | 7 | 3.5% |
| 5 | SYNCOM FORMULATIONS (INDIA) LIMITED QUININE SULPHATE TABLETS BP 300 MG. (S/C | $647.1K | 1 | 3.3% |
| 6 | NUCARE LABS LLP PHARMACEUTICAL MEDICINE FINISHED PRODUCTS- QUININEINJ. 2 ML | $565.9K | 2 | 2.9% |
| 7 | SCOTT EDIL PHARMACIA LIMITED STERILE QUININE DIHYDROCHLORIDE CONCENTRQUININE DIHYDROCHLORIDE INJ. 600 MG/ 2 MHL MEDICINES QUININE SULPHATE 300MG TABL | $548.3K | 3 | 2.8% |
| 8 | REDWING PHARMA PRIVATE LIMITED | $385.2K | 1 | 2.0% |
| 9 | KAMLA LIFESCIENCES LIMITED | $323.5K | 2 | 1.7% |
| 10 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED QUININE SULFATE TABLETS [200MG] [FC]QUININE SULFATE TABLETSQUININE SULFATE TABLETS [200MG] [FC]206 | $316.7K | 1 | 1.6% |
| 11 | AGOG PHARMA LIMITED STERILE QUININE DIHYDROCHLORIDE CONCENTRQUININE DIHYDROCHLORIDE INJ. 600 MG/ 2 MHL MEDICINES QUININE SULPHATE 300MG TABL | $258.7K | 2 | 1.3% |
| 12 | MEDOPHARM QUININE DI HCL BQUININE DIHYDROCHLORIDE INJECTION 300 MG/ML | $231.6K | 6 | 1.2% |
| 13 | USAN PHARMACEUTICALS PRIVATE LIMITED QUININE SULPHATE TABLETS BP 300 MG. (S/C | $224.5K | 1 | 1.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Quinine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Strides Pharma Science Limited | Approved | Yes | Yes | Multiple | Received FDA warning letter in July 2019; compliance achieved by May 2023. |
| Intas Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | EU GMP certified in April 2007; operates 19 manufacturing facilities globally. |
| Ciron Drugs and Pharmaceuticals Private Limited | Not Listed | Yes | Yes | Not Applicable | WHO-GMP and EU GMP certified; specializes in manufacturing and exporting pharmac |
| Syncom Formulations (India) Limited | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; focuses on manufacturing a wide range of pharmaceutical produ |
| Nucare Labs LLP | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; engaged in manufacturing and exporting pharmaceutical formula |
| Scott Edil Pharmacia Limited | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; specializes in manufacturing a diverse range of pharmaceutica |
| Redwing Pharma Private Limited | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; engaged in manufacturing and exporting pharmaceutical formula |
| Kamla Lifesciences Limited | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; focuses on manufacturing a wide range of pharmaceutical produ |
| Milan Laboratories (India) Private Limited | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; engaged in manufacturing and exporting pharmaceutical formula |
| Medopharm | Not Listed | Yes | No | Not Applicable | WHO-GMP certified; specializes in manufacturing a diverse range of pharmaceutica |
TransData Nexus reviewed the regulatory standing of 10 leading Quinine exporters from India. 2 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Quinine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous pharmaceutical companies specializing in the synthesis of APIs, which are essential for formulating various medications, including antimalarial drugs like quinine. The presence of advanced infrastructure and a skilled workforce has established Hyderabad as a critical node in India's pharmaceutical supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara belt in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to a significant number of pharmaceutical units, contributing substantially to the production of finished dosage forms. Companies in this cluster are known for their expertise in formulating and packaging medications, ensuring that APIs like quinine are effectively transformed into consumable pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a vital export gateway for India's pharmaceutical products. With its proximity to major ports and well-established logistics networks, this cluster facilitates the efficient export of pharmaceuticals, including quinine, to international markets. The region's strategic location and robust infrastructure make it a key player in the global distribution of Indian pharmaceuticals.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives offered by the government. This cluster attracts numerous pharmaceutical companies seeking cost-effective production solutions. The region's growth has bolstered India's capacity to produce a wide range of pharmaceutical products, including those containing quinine.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different pharmaceutical clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical expertise and production capacities of suppliers, particularly in API synthesis and formulation, to ensure consistent quality and supply of quinine.
- Leverage Export Infrastructure: Utilize the logistical advantages of clusters like Mumbai-Thane-Raigad for efficient international distribution of quinine products.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and market access.
By strategically engaging with these pharmaceutical clusters and adhering to these recommendations, TransData Nexus can optimize its supply chain for quinine, ensuring reliability and quality in its pharmaceutical offerings.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Quinine exporters from India
Strides Pharma Science Limited — Strides Pharma acquires remaining 50% stake in Neviton
In February 2025, Strides Pharma Science Limited completed the acquisition of the remaining 50% stake in Neviton, thereby gaining full ownership of the company. - IMPACT: This acquisition is expected to enhance Strides Pharma's production capabilities, potentially increasing their quinine export capacity.
Impact: This acquisition is expected to enhance Strides Pharma's production capabilities, potentially increasing their quinine export capacity.
Common Questions — Quinine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which quinine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, STRIDES PHARMA SCIENCE LIMITED leads with 63 recorded shipments worth $4.7M. SIDHAANT LIFE SCIENCES PRIVATE LIMITED (17 shipments) and INTAS PHARMACEUTICALS LIMITED (10 shipments) are also established high-volume exporters.
Q How many quinine manufacturers are there in India?
India has 236 active quinine exporters with a combined export market of $19.3M across 1,510 shipments to 93 countries. The top 5 suppliers hold 42.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for quinine from India?
Average FOB unit price: $22.75 per unit, ranging from $0.01 to $794.30. Average shipment value: $12.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 236 verified Indian exporters of Quinine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,510 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 93 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,510 Verified Shipments
236 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists